Videos Library
Practical strategies for implementing RWE studies in Asia Pacific
Overview
- Differences between real-world evidence studies and randomized controlled trials.
- Asia Pacific country specific examples of real-world evidence studies.
- Local regulations on study approval and execution.
- KOL value and working with investigators in APAC.
Speakers
William Maier
Chief Scientific Officer, Mapi Group, UK
Isabelle Grau
Director, Real World Evidence APAC, Mapi Group, Australia
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
